Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Allergen-specific immunotherapy in allergic rhinitis.

H J Malling1

  • 1Allergy Unit, National University Hospital, Copenhagen, Denmark. hans_joergen_rh00450_malling@rh.dk

Current Opinion in Allergy and Clinical Immunology
|April 20, 2002
PubMed
Summary

This review highlights recent advances in allergen-specific immunotherapy for allergic rhinitis. It focuses on patient selection, treatment mechanisms, optimization, and allergen presentation for effective allergy treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EAACI guidelines on allergen immunotherapy: Executive statement.

Allergy·2018
Same author

Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy ageing) and the Global Alliance against Chronic Respiratory Diseases (GARD), a World Health Organization GARD research demonstration project.

Clinical and translational allergy·2016
Same author

Dynamics of plasma levels of specific IgE in chlorhexidine allergic patients with and without accidental re-exposure.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2016
Same author

Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper.

Allergy·2014
Same author

European Academy of Allergy and Clinical Immunology task force report on 'dose-response relationship in allergen-specific immunotherapy'.

Allergy·2011
Same author

The T cell response to major grass allergens is regulated and includes IL-10 production in atopic but not in non-atopic subjects.

International archives of allergy and immunology·2010

Area of Science:

  • Allergy and Immunology
  • Immunotherapy Research
  • Otorhinolaryngology

Background:

  • Allergic rhinitis affects a significant portion of the population globally.
  • Current treatments for allergic rhinitis include pharmacotherapy and allergen-specific immunotherapy (AIT).
  • Advances in understanding immune responses necessitate updated treatment strategies.

Purpose of the Study:

  • To review significant recent publications on allergen-specific immunotherapy for allergic rhinitis.
  • To focus on key aspects: patient selection, mechanisms of action, and treatment optimization.
  • To discuss novel approaches to allergen presentation for enhanced immunotherapy efficacy.

Main Methods:

  • Selective review of high-impact articles published within the last year.

Related Experiment Videos

  • Focus on studies detailing patient stratification for AIT.
  • Analysis of research on immunological mechanisms underlying AIT.
  • Evaluation of strategies for optimizing AIT protocols and allergen delivery.
  • Main Results:

    • Recent research provides refined criteria for selecting optimal candidates for AIT.
    • New insights into the immunological mechanisms driving AIT efficacy have emerged.
    • Strategies for optimizing allergen dosage, timing, and administration routes are being developed.
    • Innovative methods for allergen presentation are showing promise in enhancing treatment outcomes.

    Conclusions:

    • Careful patient selection is crucial for successful allergen-specific immunotherapy in allergic rhinitis.
    • A deeper understanding of AIT mechanisms allows for more personalized and effective treatment strategies.
    • Optimizing allergen presentation is a key area for future advancements in AIT.